Chris Bissonette

Board Director

Chris is Managing Partner of Pallasite Ventures, a seed venture capital fund founded in 2014 to enable the positive impact of breakthrough science at scale. Pallasite has to-date invested over $30M USD in 60 companies across the US and Canada. Evaluating the potential global impact of Ionomr’s technology and recognizing the passion and intellect of Ionomr’s science team, Pallasite led and co-led Ionomr’s 3 seed rounds and Dr. Bissonnette joined its board. Prior to Pallasite, Chris spent ten years as a research scientist focusing on stem cell treatments for Alzheimer’s disease, successfully launched a startup company and then spent several years in corporate finance and venture capital.